Latest Sipuleucel-T Stories
- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.
Bankruptcy Court formally approved Valeant's role as a stalking horse bidder LAVAL, Quebec, Feb. 5, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
LAVAL, Quebec, Jan. 29, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
Researchers say that the cost of treating cancer is spiraling out of control and becoming unaffordable in many developed countries.
BETHESDA, Md., Aug.
SEATTLE, Aug. 5, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the Canaccord Genuity Growth Conference in Boston, MA on August 10 at 5:00 PM EDT.
SEATTLE, Aug. 3, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2011. Net revenue for the quarter ended June 30, 2011 was $49.6 million compared to $2.8 million for the quarter ended June 30, 2010.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.